Drug Shortages Give Ben Venue Relief In FDA Consent Decree
This article was originally published in The Pink Sheet Daily
Executive Summary
The consent decree permits the company to continue to manufacture more than 100 drugs, 20 of which are on FDA’s current drug shortage list. Ben Venue must prove compliance with good manufacturing practice requirements before it can manufacture its other drugs.
You may also be interested in...
Mylan Grabs More FDA Globalization Talent
Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.
Mylan Grabs More FDA Globalization Talent
Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.
FDA Drug Shortage Strategy: Enforcement Discretion, Patient Public Relations
Rapid approval of a new, preservative-free generic methotrexate and permission to import an unapproved version of doxorubicin touted at press conference as FDA emphasizes the success of administrative efforts.